1. Evidence of NI‐0101 pharmacological activity, an anti‐TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS. Issue 2 (17th November 2016) Authors: Monnet, E; Lapeyre, G; Poelgeest, E van; Jacqmin, P; Graaf, K de; Reijers, J; Moerland, M; Burggraaf, J; Min, C de Journal: Clinical pharmacology & therapeutics Issue: Volume 101:Issue 2(2017) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗